相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer
Pengwei Lv et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Silencing of SNHG6 induced cell autophagy by targeting miR-26a-5p/ULK1 signaling pathway in human osteosarcoma
Xin Zhu et al.
CANCER CELL INTERNATIONAL (2019)
Long non-coding RNA SNHG6 promotes cell proliferation and migration through sponging miR-4465 in ovarian clear cell carcinoma
Yong Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
Mengjia He et al.
ONCOGENE (2019)
LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis
Mingyuan Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Molecular functions and biological roles of long non-coding RNAs in human physiology and disease
Florian Kopp
JOURNAL OF GENE MEDICINE (2019)
LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells
Xinke Wang et al.
CANCER CELL INTERNATIONAL (2019)
Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression
Mengfan Pu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1
Xinke Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
The Application of lncRNAs in Cancer Treatment and Diagnosis
Yi Zhang et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma
Rui Liang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway
Yaling Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells
Ching-Ju Shen et al.
JOURNAL OF DRUG TARGETING (2017)
LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
Jihong An et al.
ONCOTARGETS AND THERAPY (2017)
Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis
Jie Wu et al.
ONCOTARGETS AND THERAPY (2017)
LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
Zheng Fang et al.
CANCER MEDICINE (2017)
lncRNA UCA1 Contributes to Imatinib Resistance by Acting as a ceRNA Against miR-16 in Chronic Myeloid Leukemia Cells
Yun Xiao et al.
DNA AND CELL BIOLOGY (2017)
TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis
Changfeng Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
X. Zhu et al.
ONCOGENE (2016)
Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel
Sayaka Sobue et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
The roles of miRNAs as potential biomarkers in lung diseases
Shamila D. Alipoor et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC)
Jinjun Ye et al.
MOLECULAR BIOSYSTEMS (2016)
Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b
Qun Fang et al.
MEDICAL SCIENCE MONITOR (2016)
Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity
Jessica E. Jorvig et al.
ANTI-CANCER DRUGS (2015)
Long noncoding RNA turnover
Je-Hyun Yoon et al.
BIOCHIMIE (2015)
Aberrant Regulation and Function of MicroRNAs in Cancer
Brian D. Adams et al.
CURRENT BIOLOGY (2014)
MiRNA as potential biomarkers and therapeutic targets for gastric cancer
Vivian Yvonne Shin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for standardized definition
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
分享论文
